Our previous studies have suggested that the interaction between hyaluronic acid (HA) on peritoneal mesothelial cells and the membrane adhesion molecule, CD44, on ovarian tumour cells could be important in ovarian cancer metastasis. In order to study this further, adhesion of six ovarian tumour lines to HA coated on to a plastic surface was investigated. Four lines bound to the HA coat and two lines did not. The adhesive lines were those that expressed high amounts of CD44, but the degree of adhesion was not closely correlated with CD44 expression. The results suggested that different tumour lines had different affinities for HA. Treatment of the HA coat with hyaluronidase substantially reduced adhesion. Adhesion was also partially reduced if the tumour cells were preincubated with either soluble HA, or anti-CD44 antibodies directed against the HA binding region. An antibody against a non-HA binding region only slightly blocked adhesion at high antibody concentrations. Only the CD44H isoform was detected by immunoprecipitation on the tumour cells. These results suggest that ovarian tumour cells can attach to immobilised HA via CD44H on the cell membrane.
Similar content being viewed by others
References
Surveys, Office of Population Censuses and Surveys, 1994. Cancer Statistics 1989, HMSO.
Hoskins WJ, 1993, Surgical staging and cytoreductive surgery of epithelial ovarian cancer. Cancer, 71, 1534–40.
Fox H, 1990, Pathology of ovarian cancer. In: Shepherd J and Monaghan J, eds. Clinical Gynaecological Cancer. Oxford: Blackwell Scientific Publishers, pp. 188–217.
Lesley J, Hyman R, and Kinkade PW, 1993, CD44 and its interaction with extracellular matrix. Adv in Immunol, 54, 271–335.
Catterall JB, Gardner MJ and Turner GA, 1995, Hyaluronic acid, cell adhesion and metastasis. The Cancer J, 8, 320–4.
Guo YJ, Ma J, Wang JH, et al., 1994, Inhibition of human-melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res, 54, 1561–5.
Sy MS, Guo YJ and Stamenkovic I, 1991, Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med, 174, 859–66.
Sy MS, Guo YJ and Stamenkovic I, 1992, Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J Exp Med, 176, 623–7.
Sleeman J, Moll J, Sherman L, et al., 1995, The role of CD44 splice variants in human metastatic cancer. Ciba Foundation Symposium, 189, 142–56.
Knudson W, Biswas C and Toole BP, 1984, Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis. Proc Natl Acad Sci, 81, 6767–71.
Toole BP, Biswas C and Gross J, 1979, Hyaluronate and invasiveness of the rabbit V2 carcinoma. Proc Natl Acad Sci, 76, 6299–303.
Turley EA, Austen K, Vandeligt K and Clarey C, 1991, Hyaluronan and cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J Cell Biol, 112, 1041–7.
Rooney P, Kumar S, Pouting J and Wang M, 1995, The role of hyaluronan in tumour neovascularization. Int J Cancer, 60, 632–6.
Gardner MJ, Jones LMH, Catterall JB and Turner GA, 1995, Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis. Cancer Lett, 91, 229–34.
Jones LMH, Gardner JB, Catterall JB and Turner GA, 1995, Hyaluronic acid secreted by mesothelial cells: a natural barrier to ovarian cancer cell adhesion. Clin Exp Metastasis, 13, 373–80.
Hills CA, Kelland LR, Abel G, Sirachy J, Wilson AP and Harrap KR, 1989, Biological properties of ten human ovarian caricinoma cell lines: calibration in vitro against four platinium complexes. Br J Cancer, 59, 527–34.
Mobus V, Gerharz CD, Press V, et al., 1992, Morphological, immunological, histochemical and biochemical characterisation of 6 newly established human ovarian tumour carcinoma cell lines. Int J Cancer, 52, 76–84.
Catterall JB, Gardner MJ, Jones LMH and Turner GA, 1994, A precise, rapid and sensitive in vitro assay to measure the adhesion of ovarian tumour cells to peritoneal mesothelial cells. Cancer Lett, 87, 199–203.
Stern P, Gilbert P, Sternberg S, Thompson S, Chada K, 1984, A monoclonal antibody which detects a 125kD glycoprotein on embryonal carcinoma cells and is mitogenic for murine spleen cells. J Reprod Immunol, 6, 313–28.
Cannistra SA, Kansas GS, Niloff J, Defranzo B, Kim Y and Ottensmeier C, 1993, Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res, 53, 3830–8.
Lee JH, Kang Y-S, Kim B-G, et al, 1995, Expression of the CD44 adhesion molecule in primary and metastatic gynecologic malignancies and their cell lines. Int J Gynecol Cancer, 5, 193–9.
Cannistra SA, Abu-Jawdeh G, Niloff J, et al., 1995, CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors. J Clin Oncol, 13, 1912–21.
Fox SB, Fawcett J, Jackson DG, et al., 1994, Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res, 54, 4539–46.
Anstee DJ, Gardner B, Spring FA, et al., 1991, New monoclonal antibodies in CD44 and CD58: their use to quantify CD44 and CD58 on normal human erythrocytes and to compare the distribution of CD44 and CD58 in human tissues. Immunol, 74, 197–205.
Belitsos PC, Hildreth JEK and August JT, 1990, Homotypic cell aggregation induced by anti-CD44 (Pgp-1) monoclonal antibodies and related to CD44 (Pgp-1) expression. J Immunol, 144, 1661–70.
Culty M, Miyake K, Kincade PW, et al., 1990, The hyaluronan receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol, 111, 2765–74.
East JA, Mitchell SD and Hart IR, 1993, Expression and function of the CD44 glycoprotein in melanoma cell lines. Melanoma Res, 3, 341–6.
Bennett KL, Modrell B, Greenfield B, et al., 1995, Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J Cell Biol, 131, 1623–33.
Lesley J, English N, Perschl A, Gregoroff J and Hyman R, 1995, Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med, 182, 431–7.
Katoh S, Zheng Z, Oritani K, Shimozato T and Kinkade PW, 1995, Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med, 182, 419–29.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gardner, M.J., Catterall, J.B., Jones, L.M.H. et al. Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: a possible step in peritoneal metastasis. Clin Exp Metast 14, 325–334 (1996). https://doi.org/10.1007/BF00123391
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00123391